etry is a viable signaling complex [12, 13].
strand F, as well as the BC, C'E, and FG loops of the second FNIII domain (D2). Figure 3 shows a surface representation of the receptor. Superimposed on this surface is the set of the hormone residues that lose exposed surface area upon complex formation. The hydrophobic receptor residues Tyr49, Trp82, Val206, and Trp207 account for ‫%04ف‬ of the buried surface of the receptor. In contrast, four hydrophilic residues account for approximately onethird of the hormone buried surface: Ser20, Ala23 (main chain), His111', and Gln115'. A dominant feature of this interaction is the protruding surface created by IFN-␥R␣ residues Tyr49, Trp82, and Glu101. This "knob" sits in a "hole" on the surface of the IFN-␥ molecule bounded by residues His111' and Glu112' on one side and by the loop connecting helices A and B on the other.
Another interacting surface is created by the receptor ing the ␥ turn conformation is offset by the efficiency molecules, as well as the nature and size of the interface, appear similar to the 2.0 Å resolution structure prewith which this conformation can provide the full effect of the side chains of this tripeptide to the binding insented here. There are, however, several pertinent differences between the two models that have implications terface.
There is no interpretable electron density for the six to the interpretation of the roles of certain residues in the hormone-receptor interface. Additionally, the higher C-terminal residues of the scIFN-␥ construct. 
Intermolecular H-Bonding Interactions
There are eight hydrogen bonds and two salt bridges (Ͻ 3.2 Å ) in the hormone-receptor interface (Table 1) . Three of these H-bonds are main chain-main chain, three are side chain-main chain, and two are side chainside chain. Examination of the hormone-receptor interface indicates water molecules play a significant role in the binding properties of the interface. There are five water molecules that bridge the donor-acceptor groups of the hormone and receptor through H-bonding (Table  2) cally referred to as disallowed [21] . Given the similarity vates the hormone, involves a specific charge repulsion feature. Based on this structure, the repulsion could be of the two complexes and the fact that this residue is located in the hormone-receptor interface, it seems directly influenced by the relatively close proximity of the Asp to Glu101. unlikely that the conformation of this amino acid differs between the two structures. Instead, the lower resolution of the 1:2 structure probably masked a clear inter- Figure 5b shows the electron density in the region of tures that are both common and distinct between these two classes. His111' and illustrates the importance of high-resolution data in structural interpretation. In the assigned conforThe structural topology is similar for both IFN-␥R␣ and hGHR. One notable difference between them is the mation, the imidazole side chain H-bonds to the carbonyl oxygen of Ala17 (2.9 Å ) of the hormone and orientation between their two FNIII domains. Following superposition of the C-terminal domains, an ‫03ف‬Њ rotathrough its N⑀2 to a water (2.9 Å ) that is an integral part of a four-water network bridging the hormone-receptor tion is required to align the N-terminal domains. As a result of the more linear arrangement for the two dointerface (Figure 5a) . Besides H-bonding to His111', this water coordinates the N⑀2 of Gln115Ј of the hormone mains in IFN-␥R␣, the loop connecting ␤ strands A and B, part of the ligand binding epitope for the hGHR, is and the peptide amide of Ser80 of the receptor. Although Glu101 of the receptor is close to the imidazole ring buried in the domain-domain interface of IFN-␥R␣ (Figure 6) . of His111' (3.2 Å ), the stereochemistry of the above H-bonding scheme unequivocally defines the conformaDespite the difference in orientation, the two receptors still use residues from many of the same structural tion of the ring in a position where they cannot H-bond. Note that changing His111' to one of several side chain elements to bind their respective hormones. While both receptors use a section of their C-terminal domains for types has little apparent effect on binding [26] , suggesting that the specific mutation to Asp, which inactihormone binding, it is the N-terminal domains that con- [18] receptors. While it has been speculated that these These residues are positioned in close spatial proximity.
residues present a surface that may be recognized by In the case of IFN-␥, Ala-scanning mutagenesis shows an accessory protein [6], to date no biological function that the binding energy has a much broader spatial dishas been assigned to this motif. tribution (G. Pal, unpublished data). 
While the binding energetics of residues in hGHR that

hGH. The erythropoietin (EPOR) receptor has a similar
The wild-type IFN-␥ and six variants were tested for hydrophobic "hot spot" [20] . Analysis of the IFN-␥:IFNbiological activity in a viral protection assay using A549 ␥R␣ complex reveals that a portion of the interface has cells derived from a human lung cell carcinoma [28] . a disposition of aromatic residues similar to W104 and Three of these molecules had the native two-chain con-W169 in the hGH:hGHR complex. Tyr49 and Trp82 of struction; the other four were based on the single-chain IFN-␥R␣ bind in a cleft between the AB loop and the format. These molecules contain elements that either C-terminal helix of IFN-␥. The similarity of these two sites affected none, one, or both of the potential receptor would suggest a major energetic binding contribution binding sites. A description of these molecules and their from Tyr49 and Trp82, but detailed mutational and bindbiological activity is presented in Table 3 
